Hengrui Medicine (01276.HK): HRS-4508 tablets approved for clinical trials.

Intelligent Wealth Finance APP News, Hengrui Medicine (01276.HK) announced that recently, the company received the National Medical Products Administration's approval and issuance of the "Notice of Approval for Drug Clinical Trial" for HRS-4508 tablets, and will soon conduct clinical trials.